Skip to content
March 28, 2024

Equity.Guru

Investment information for the new generation

Search

valeo pharma

Valeo Pharma (VPH.C) has gotten their their Hesperco flavonoid formulation on shelves at over 300 stores under the Loblaws brand, including Loblaws, Dominion, Zehs, Fortinios, Your Independent Grocer and…
Valeo Pharma Inc. (VPH.C) announced today that it has successfully entered into a Product Listing Agreement (PLA) with the Quebec Minister of Health. According to this agreement, the Company…
Even during my university days, I would find myself grasping my chest, wheezing after a short 15-minute walk to campus. In terms of fitness, I would consider myself to…
Valeo Pharma (VPH.C) is a specialty pharmaceutical company, engages in the acquisition, in-licensing, and commercialization of pharmaceutical products with a primary focus on neurodegenerative diseases, oncology and supportive care, and…
Valeo (VPH.C), a specialty pharma company, announced early today that it has obtained listings for Redesca from two group purchasing organizations (“GPO”) on behalf of +700 hospitals and health…
Welcome to Equity.Guru’s Roundtable where our writers weigh in on the pros and cons of a spotlight company, break out where they see value, and help you avoid public…
Valeo Pharma (VPH.C) announced today that it has completed implementation of its new corporate structure and launched full commercial activities in support of Enerzair Breezhaler triple therapy and Atectura…
I am writing about Valeo Pharma Inc. at a very fascinating time for biotech/health stocks. Recently, Biotech has been hot! Led by the vaccine companies which are soaring. Just…
Steve Saviuk, president and CEO of Valeo Pharma (VPH.C), talks about the transformative partnerships with international players such as Novartis and members of the Canadian Healthcare Industry, that allow…
Welcome to Equity.Guru’s Roundtable where our writers weigh in on the pros and cons of a spotlight company, break out where they see value, and help you avoid public…